Comparing the FDA new drug approval lists from 2023 and 2024 reveals a significant difference in the size of the companies that achieved the regulatory triumphs. In 2023, among the 68 FDA approvals ...

In 2024, multiple drugs received complete response letters (CRLs), sometimes unrelated to the safety and efficacy of the drug, but patients with schizophrenia gained the first new treatment with a new ...

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the American Enterprise Institute ...

The inflationary rebate provisions of the Inflation Reduction Act (IRA) of 2022 require pharmaceutical manufacturers to pay money back to Medicare if they raise prices faster than the rate of ...

Two-thirds of pharmaceutical companies did not proactively release the launch price of their medications from 2022 to 2024. Objective: To examine how drug manufacturers disclosed prices for new ...